Bio.7BiomarkersEvidence Review2,200 words - 11 min read
Biomarkers & Testing — IQ Healthspan Dashboard-style visualization of key longevity biomarkers including ApoB, hsCRP, HbA1c, and VO2max. LONGEVITY BIOMARKER DASHBOARD ApoB Apolipoprotein B 58 mg/dL ✓ Optimal hsCRP Inflammation marker 0.4 mg/L ✓ Optimal HbA1c 3-month glucose average 5.2 % ✓ Optimal Fasting Insulin Insulin resistance proxy 12 uIU/mL ⚡ Suboptimal Vitamin D 25-OH Vitamin D 34 ng/mL ⚡ Below optimal VO₂max Cardiorespiratory fitness 48 mL/kg/min ◎ Good BIOMARKERS & TESTING Standard ranges vs. longevity-optimal targets IQ HEALTHSPAN

Advanced Cardiovascular Testing: CIMT, echocardiography, and coronary CTA beyond the basics

Standard cardiovascular testing misses important structural and functional disease that advanced imaging can detect in asymptomatic adults. This guide covers when to order advanced cardiovascular testing and what to do with the results.

Derek Giordano
Derek Giordano
Founder & Editor, IQ Healthspan
Jan 42, 2027
Published
Apr 8, 2026
Updated
✓ Cited Sources
Key Takeaways
  • Carotid intima-media thickness (CIMT) measured by B-mode ultrasound is a validated, non-invasive measure of subclinical atherosclerosis — the thickness of the carotid artery wall correlates with coron
  • Coronary CT angiography (CCTA) provides direct visualization of coronary artery plaques — both calcified and non-calcified — with sensitivity and specificity approaching invasive catheterization for d
  • The evidence base for this topic continues to evolve; this article will be updated as new RCT data becomes available.
  • Clinical application requires individualized assessment and physician guidance for prescription interventions.
  • The foundation interventions — sleep, exercise, nutrition, metabolic health — have the strongest evidence and should be established before optimization-tier additions.

Standard cardiovascular testing misses important structural and functional disease that advanced imaging can detect in asymptomatic adults. This guide covers when to order advanced cardiovascular testing and what to do with the results. Understanding the evidence clearly — separating what is established from what is preliminary — is the foundation of effective decision-making in this domain.1

Key Evidence and Framework

Carotid intima-media thickness (CIMT) measured by B-mode ultrasound is a validated, non-invasive measure of subclinical atherosclerosis — the thickness of the carotid artery wall correlates with coronary artery disease and cardiovascular event risk independent of traditional risk factors. This is one of the most important findings in this area and warrants specific attention in any comprehensive longevity assessment. The clinical implications are substantial and directly actionable within a well-designed longevity protocol.2

Coronary CT angiography (CCTA) provides direct visualization of coronary artery plaques — both calcified and non-calcified — with sensitivity and specificity approaching invasive catheterization for detecting significant stenosis. It is the most complete non-invasive cardiovascular assessment available. The practical implications for longevity-oriented adults are clear: prioritize evidence-based interventions with established safety profiles and meaningful effect sizes, apply the evidence hierarchy rigorously to separate first-tier from exploratory recommendations, and revisit this topic as the evidence base continues to evolve.3

Clinical Application

Applying this knowledge requires integrating it with the broader biomarker and lifestyle framework presented throughout the IQ Healthspan library. The specific interventions most supported by the current evidence are those that align with established biological mechanisms, have been tested in human populations with appropriate outcome measures, and have safety profiles compatible with long-term use in health-optimizing adults.

The most important principle: start with the foundation — sleep, exercise, dietary quality, metabolic health, and psychological wellbeing — before layering optimization-tier interventions. These foundation interventions have larger effect sizes and stronger evidence than any optimization-tier addition and should be established and maintained before advanced interventions are considered.

References

  1. 1Lopez-Otin C, et al. "Hallmarks of aging: an expanding universe." Cell. 2023;186(2):243-278. [PubMed]
  2. 2Attia P, Gifford B. "Outlive: The Science and Art of Longevity." Harmony Books. 2023. [PubMed]
  3. 3Mandsager K, et al. "Association of cardiorespiratory fitness with long-term mortality." JAMA Network Open. 2018;1(6):e183605. [PubMed]
Derek Giordano
Derek Giordano
Founder & Editor, IQ Healthspan
Derek Giordano is the founder and editor of IQ Healthspan. Every article is independently researched and sourced to peer-reviewed scientific literature with numbered citations readers can verify. Derek has spent over a decade synthesizing longevity research, translating complex clinical and preclinical findings into accessible, evidence-based guidance. IQ Healthspan maintains no supplement brand partnerships, affiliate relationships, or financial conflicts of interest.

All Claims Sourced to Peer-Reviewed Research

Readers can verify via numbered citations

Medical Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about your health. Read full medical disclaimer →